During the past decade, Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin" #1 collaborator was "Center for Sepsis Control and Care, Germany" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Instituto Grifols, S.A." with 1 trials as a collaborator, "SepNet - Critical Care Trials Group" with 1 trials as a collaborator and "The Center for Clinical Trials (ZKS), Jena" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin" are "Septic Shock" (2 trials) and "ARDS" (1 trials). Many other conditions were trialed in "Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adrecizumab" (1 trials), "Albutein® 200 g/L or Plasbumin® 20" (1 trials), "Placebo" (1 trials), "inhaled molgramostim (rhGM-CSF)" (1 trials) and "inhaled placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".